Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, Pesudovs K, Price H, White RA, Wong TY, Resnikoff S, Taylor HR. Global estimates on the number of People Blind or visually impaired by Diabetic Retinopathy: a Meta-analysis from 1990 to 2010. Diabetes Care. 2016;39(9):1643–9. https://doi.org/10.2337/dc15-2171.

Article  PubMed  Google Scholar 

Kawasaki R, Tanaka S, Tanaka S, Yamamoto T, Sone H, Ohashi Y, Akanuma Y, Yamada N, Yamashita H. Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes complications Study (JDCS). Diabetologia. 2011;54(9):2288–94. https://doi.org/10.1007/s00125-011-2199-0.

Article  CAS  PubMed  Google Scholar 

Yi QX, Zhu LN, Ma J, Yu XJ, Liu L, Shen J. Use of Anthropometric Measures of Obesity to Predict Diabetic Retinopathy in patients with type 2 diabetes in China. Diabetes Metab Syndr Obes. 2021;14:4089–95. https://doi.org/10.2147/dmso.S321030.

Article  PubMed  PubMed Central  Google Scholar 

Sasongko MB, Widyaputri F, Sulistyoningrum DC, Wardhana FS, Widayanti TW, Supanji S, Widyaningrum R, Indrayanti SR, Widhasari IA, Agni AN. Estimated resting metabolic rate and body composition measures are strongly Associated with Diabetic Retinopathy in Indonesian adults with type 2 diabetes. Diabetes Care. 2018;41(11):2377–84. https://doi.org/10.2337/dc18-1074.

Article  PubMed  Google Scholar 

Chen J, Wan Y, Su J, Zhu Z, Pan E, Shen C, Wen J, Wang K, Yu H, Qin Y, Cui L, Zhou J, Wu M. Association of Generalized and Abdominal Obesity with Diabetic Retinopathy in Chinese Type 2 Diabetic patients. Acta Diabetol. 2022;59(3):359–67. https://doi.org/10.1007/s00592-021-01806-7.

Article  PubMed  Google Scholar 

Sabanayagam C, Sultana R, Banu R, Rim T, Tham YC, Mohan S, Chee ML, Wang YX, Nangia V, Fujiwara K, Tai ES, Song SJ, Bikbov MM, Raman R, Cheng CY, Wong TY, Jonas JB. Association between body mass index and diabetic retinopathy in asians: the Asian Eye Epidemiology Consortium (AEEC) study. Br J Ophthalmol. 2022;106(7):980–6. https://doi.org/10.1136/bjophthalmol-2020-318208.

Article  PubMed  Google Scholar 

Verma A, Jha A, Alagorie AR, Sharma R. Association of anthropometric parameters as a risk factor for development of diabetic retinopathy in patients with diabetes mellitus. Eye. 2023;37(2):303–8. https://doi.org/10.1038/s41433-022-01934-6.

Article  PubMed  Google Scholar 

Li X, Li HY, Yu ZW, Zhang YT, Tong XW, Gao XY. Association among lipid Accumulation product, Chinese visceral obesity Index and Diabetic Retinopathy in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2021;14:4971–9. https://doi.org/10.2147/dmso.S348195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vasan SK, Osmond C, Canoy D, Christodoulides C, Neville MJ, Di Gravio C, Fall CHD, Karpe F. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes. 2018;42(4):850–7. https://doi.org/10.1038/ijo.2017.289.

Article  CAS  Google Scholar 

Ma W, Zhu H, Yu X, Zhai X, Li S, Huang N, Liu K, Shirai K, Sheerah H.A., Cao J. Association between android fat mass, gynoid fat mass and cardiovascular and all-cause mortality in adults: NHANES 2003–2007. Front Cardiovasc Med. 2023;10:1055223. https://doi.org/10.3389/fcvm.2023.1055223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding L, Fan Y, He J, Wang R, He Q, Cui J, Ma Z, Zheng F, Gao H, Dai C, Wei H, Li J, Cao Y, Hu G, Liu M. Different indicators of Adiposity and Fat distribution and cardiometabolic risk factors in patients with type 2 diabetes, obesity (Silver Spring. Md). 2021;29(5):837–45. https://doi.org/10.1002/oby.23151.

Article  CAS  Google Scholar 

Wei S, Nguyen TT, Zhang Y, Ryu D, Gariani K. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol (Lausanne). 2023;14:1185221. https://doi.org/10.3389/fendo.2023.1185221.

Article  PubMed  Google Scholar 

Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies, Nature reviews. Endocrinology. 2018;14(9):513–37. https://doi.org/10.1038/s41574-018-0062-9.

Article  PubMed  Google Scholar 

Wang M, Tan Y, Shi Y, Wang X, Liao Z, Wei P. Diabetes and sarcopenic obesity: Pathogenesis, diagnosis, and treatments. Front Endocrinol (Lausanne). 2020;11:568. https://doi.org/10.3389/fendo.2020.00568.

Article  PubMed  Google Scholar 

Fukuda T, Bouchi R, Takeuchi T, Tsujimoto K, Minami I, Yoshimoto T, Ogawa Y. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. 2018;17(1):55. https://doi.org/10.1186/s12933-018-0700-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seo DH, Suh YJ, Cho Y, Ahn SH, Seo S, Hong S, Lee YH, Choi YJ, Lee E, Kim SH. Effect of low skeletal muscle mass and sarcopenic obesity on chronic kidney disease in patients with type 2 diabetes. Obes (Silver Spring Md). 2022;30(10):2034–43. https://doi.org/10.1002/oby.23512.

Article  Google Scholar 

Fukuda T, Bouchi R, Takeuchi T, Nakano Y, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Association of diabetic retinopathy with both Sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study. BMJ Open Diabetes Res Care. 2017;5(1):e000404. https://doi.org/10.1136/bmjdrc-2017-000404.

Article  PubMed  PubMed Central  Google Scholar 

Chap. 1: Definition and classification of CKD, Kidney international supplements 3(1). (2013) 19–62https://doi.org/10.1038/kisup.2012.64

Seidu S, Barrat J, Khunti K. Clinical update: the important role of dual kidney function testing (ACR and eGFR) in primary care: identification of risk and management in type 2 diabetes. Prim Care Diabetes. 2020;14(4):370–5. https://doi.org/10.1016/j.pcd.2020.02.006.

Article  PubMed  Google Scholar 

Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet (London England). 2010;376(9735):124 – 36. https://doi.org/10.1016/s0140-6736(09)62124-3.

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H, Asian Working Group for Sarcopenia. 2019 Consensus Update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7. https://doi.org/10.1016/j.jamda.2019.12.012.

Article  PubMed  Google Scholar 

Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS ONE. 2009;4(9):e7038. https://doi.org/10.1371/journal.pone.0007038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, Ergun DL. Dual-energy X-ray absorptiometry for quantification of visceral fat, obesity (Silver Spring. Md). 2012;20(6):1313–8. https://doi.org/10.1038/oby.2011.393.

Google Scholar 

P. World Health Organization. Regional Office for the Western, the Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.

Google Scholar 

Han X, Wu H, Li Y, Yuan M, Gong X, Guo X, Tan R, Xie M, Liang X, Huang W, Liu H, Wang L. Differential Effect of generalized and abdominal obesity on the Development and Progression of Diabetic Retinopathy in Chinese adults with type 2 diabetes. Front Med (Lausanne). 2022;9:774216. https://doi.org/10.3389/fmed.2022.774216.

Article  PubMed  Google Scholar 

Li W, Gong X, Wang W, Xiong K, Meng J, Li Y, Wang L, Liang X, Jin L, Huang W. Association of different kinds of obesity with diabetic retinopathy in patients with type 2 diabetes. BMJ Open. 2022;12(5):e056332. https://doi.org/10.1136/bmjopen-2021-056332.

Article  PubMed  PubMed Central  Google Scholar 

Hwang IC, Bae JH, Kim JM. Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea, Eye (London, England) 33(6) (2019) 980–987.https://doi.org/10.1038/s41433-019-0352-z

Messina C, Albano D, Gitto S, Tofanelli L, Bazzocchi A, Ulivieri FM, Guglielmi G, Sconfienza LM. Body composition with dual energy X-ray absorptiometry: from basics to new tools. Quant Imaging Med Surg. 2020;10(8):1687–98. https://doi.org/10.21037/qims.2020.03.02.

Article  PubMed  PubMed Central  Google Scholar 

Seravalle G, Grassi G, System SN. Hypertension, obesity and metabolic syndrome, high blood pressure & cardiovascular prevention. Official J Italian Soc Hypertens. 2016;23(3):175–9. https://doi.org/10.1007/s40292-016-0137-4.

CAS  Google Scholar 

Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Disease. 2016;5:2048004016633371. https://doi.org/10.1177/2048004016633371.

Article  Google Scholar 

Fu X, Song A, Zhou Y, Ma X, Jiao J, Yang M, Zhu S. Association of regional body fat with metabolic risks in Chinese women. Public Health Nutr. 2014;17(10):2316–24. https://doi.org/10.1017/s1368980013002668.